Wednesday, 1st of October 2014 |
FOUR ITEMS ON THE ECONOMICS OF MEASLES AND MEASLES VACCINATION INNOVATIONS
THE ECONOMIC BURDEN OF 16 MEASLES OUTBREAKS ON U.S. PUBLIC HEALTH DEPARTMENTS IN 2011
http://www.measlesupdates.org/?content=com_articles&artid=1990
ECONOMIC CONSIDERATIONS FOR THE ERADICATION ENDGAME
http://www.measlesupdates.org/?content=com_articles&artid=1989
THE ECONOMIC DISEASE BURDEN OF MEASLES IN JAPAN
http://www.measlesupdates.org/?content=com_articles&artid=1988
USING COST-EFFECTIVENESS ANALYSIS TO SUPPORT RESEARCH AND DEVELOPMENT PORTFOLIO PRIORITIZATION FOR PRODUCT INNOVATIONS IN MEASLES VACCINATION
http://www.measlesupdates.org/?content=com_articles&artid=1987
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41209823 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |